Form 4 Tracker
Michael J. Farrell

Director; Director, Chairman and CEO · 10 filings · Latest: Aug 7, 2026

RESMED INC
ZIMMER BIOMET HOLDINGS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RMD
Michael J. FarrellDirector, Chairman and CEOAug 7, 2026
Sale
$205.694,991$1.0M466,256
RMD
Michael J. FarrellDirector, Chairman and CEOAug 7, 2026
Option Exercise
$146.344,991$730.4K471,247
RMD
Farrell Michael J.Aug 7, 2026
Proposed Sale
$205.694,991$1.0M
RMD
Michael J. FarrellDirector, Chairman and CEOJul 7, 2026
Sale
$218.554,991$1.1M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOJul 7, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.Jul 7, 2026
Proposed Sale
$219.344,991$1.1M
RMD
Michael J. FarrellDirector, Chairman and CEOJun 8, 2026
Sale
$193.964,991$968.1K466,256
RMD
Michael J. FarrellDirector, Chairman and CEOJun 8, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.Jun 8, 2026
Proposed Sale
$194.004,991$968.3K
RMD
Michael J. FarrellDirector, Chairman and CEOMay 7, 2026
Sale
$207.824,991$1.0M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOMay 7, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.May 7, 2026
Proposed Sale
$207.824,991$1.0M
RMD
Michael J. FarrellDirector, Chairman and CEOApr 7, 2026
Sale
$225.504,991$1.1M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOApr 7, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.Apr 7, 2026
Proposed Sale
$225.504,991$1.1M
RMD
Michael J. FarrellDirector, Chairman and CEOMar 9, 2026
Sale
$251.034,991$1.3M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOMar 9, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.Mar 9, 2026
Proposed Sale
$250.084,991$1.2M
RMD
Michael J. FarrellDirector, Chairman and CEOFeb 9, 2026
Sale
$273.784,991$1.4M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOFeb 9, 2026
Option Exercise
$146.344,991$730.4K471,214

Page 1 of 2

Next →